Suppliers / Pharmaron Manufacturing Services (UK)
Pharmaron Manufacturing Services (UK)
United Kingdom Updated 9 July 2026
Pharmaron Manufacturing Services (UK) is an API manufacturer based in United Kingdom. It holds one active US drug master file and one valid CEP. Its GMP standing is certified by US FDA and MHRA (UK). Its most recent recorded inspection, by US FDA, closed on 17 July 2025 as NAI.
4
registered plants
2 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 17 July 2025 NAI US FDA
- 24 February 2022 VAI US FDA
- 23 January 2020 VAI US FDA
- 24 May 2018 VAI US FDA
- 27 July 2016 VAI US FDA
- 11 September 2015 VAI US FDA
- 15 August 2014 VAI US FDA
- 21 March 2012 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| CRAMLINGTON, United Kingdom | Not on file |
| Cramlington, United Kingdom | Not on file |
| United Kingdom, United Kingdom | 3002806562 |
| Coventry, United States | 1211201 |
What they file, and where
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | None | 1 |
| MHRA (UK) | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Pharmaron Manufacturing Services (UK) comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was NAI, on 17 July 2025.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates